Coronavirus 2019-2020 thread (no unsubstantiated rumours!)

daifo

Captain
Registered Member
There has to be a better way than the complete lockdown that some cities are experiencing in some major Chinese cities. Covid will continue becoming a wack a mole situation which adversaries external or internal would take advantage of.

The title of the piece is dumb, but i thought it was fair reporting. This cnn reporter mentions even though they are tested everyday and negative, they still cannot leave their compound. As they mention at the end, like they understand why for some measures like daily testing but some measures are just too much .

 

KYli

Brigadier
There has to be a better way than the complete lockdown that some cities are experiencing in some major Chinese cities. Covid will continue becoming a wack a mole situation which adversaries external or internal would take advantage of.

The title of the piece is dumb, but i thought it was fair reporting. This cnn reporter mentions even though they are tested everyday and negative, they still cannot leave their compound. As they mention at the end, like they understand why for some measures like daily testing but some measures are just too much .

There is no better way. It is either locking down or living with the covid. For lock down, there are only a few options, Shenzhen mass testing with 7 days strict lock down, Beijing mass testing with long duration soft lock down, or Shanghai no mass testing with complete lock down.

As for this CNN reporter, he is just typical Westerner and liberal. Mass testing isn't going to make a dent in cutting off transmission chain if there are already hundreds of cases in the community. Shanghai is too late for simply relying upon mass testing to contain the virus. By allowing people leaving their compound would mean that the lock down would never be able to cut off the transmission chain.
 

supercat

Major
Another oral drug to start clinical trials:
Simcere’s Covid-19 Prevention Pill Is First in China to Get Green Light to Start Clinical Trials

(Yicai Global) May 18 -- Chinese drug developer Jiangsu Simcere Pharmaceutical has been given the go-ahead from China’s regulators to start clinical trials of its orally-taken Covid-19 prevention medicine in the country’s first such approval.
...
The drug can be used among close contacts of Covid-19 cases in post-exposure prophylaxis, which means receiving medical treatment within a certain period of being exposed to a pathogen. If SIM0417 goes to market, it will greatly reduce health departments’ workload of having to manage close contacts, it said.
...
US biomedical giant Pfizer has tried to use its Covid-19 pill Paxlovid in post-exposure prophylaxis but was not successful. Paxlovid mainly targets the delta variant, so it is not as effective with the omicron strain, Simcere said. Pfizer also used a contact period of 96 hours for the trials, which affected the final results.

Simcere is also exploring the use of SIM0417 to treat Covid-19 patients.
Please, Log in or Register to view URLs content!

The situations in Taiwan, Australia, and the U.S. are not good:


 
Top